ASO visual abstract: The clinical utility of a 7-gene biosignature on radiation therapy decision making in patients with ductal carcinoma in situ following breast-conserving surgery: An updated analysis of the DCISionRT PREDICT study

Authors

• Chirag Shah, Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. shahc4@ccf.org.
• Pat Whitworth, Nashville Breast Center, Nashville, TN, USA.
• Frank A. Vicini, Michigan Healthcare Professionals, Farmington Hills, MI, USA.
• Steven Narod, Center for Global Health, University of Toronto, Toronto, Canada.
• Naamit Gerber, Department of Radiation Oncology, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA.
• Sachin R. Jhawar, Department of Radiation Oncology, James Cancer Center, Ohio State University, Columbus, OH, USA.
• Tari A. King, Department of Surgery, Dana-Farber Cancer Institute, Boston, MA, USA.
• Elizabeth A. Mittendorf, Department of Surgery, Dana-Farber Cancer Institute, Boston, MA, USA.
• Shawna C. Willey, Schar Cancer Institute, Inova, Fairfax, VA, USA.
• Rachel Rabinovich, Advocate Health - Midwest
• Linsey Gold, Comphrensive Breast Care, Michigan Healthcare Professionals, Troy, MI, USA.
• Eric Brown, Comphrensive Breast Care, Michigan Healthcare Professionals, Troy, MI, USA.
• Anushka Patel, Arizona Center for Cancer Care, Phoenix, AZ, USA.
• John Vargo, Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA.
• Parul N. Barry, Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA.
• David Rock, GenesisCare, Fort Myers, FL, USA.
• Neil Friedman, Mercy Medical Center, Baltimore, MD, USA.
• Gauri Bedi, Mercy Medical Center, Baltimore, MD, USA.
• Sandra Templeton, Department of Surgery, Houston Methodist, Sugar Land, TX, USA.
• Sheree Brown, Wellstar Radiation Oncology, Hiram, GA, USA.
• Robert Gabordi, BayCare Medical Group, Tampa, FL, USA.
• Lee Riley, St. Luke's Hospital, Allentown, PA, USA.
• Lucy Lee, Northwell Health, New Hyde Park, NY, USA.
• Paul Baron, Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
• Lonika Majithia, Radiation Oncology Associates, Fairfax, VA, USA.
• Kristina L. Mirabeau-Beale, GenesisCare, Fort Myers, FL, USA.
• Vincent J. Reid, Hall-Perrine Cancer Center, Cedar Rapids, IA, USA.
• Arica Hirsch, Advocate Health - MidwestFollow
• et al

Recommended Citation

Shah C, Whitworth P, Vicini FA, Narod S, Gerber N, Jhawar SR, King TA, Mittendorf EA, Willey SC, Rabinovich R, Gold L, Brown E, Patel A, Vargo J, Barry PN, Rock D, Friedman N, Bedi G, Templeton S, Brown S, Gabordi R, Riley L, Lee L, Baron P, Majithia L, Mirabeau-Beale KL, Reid VJ, Hirsch A, Hwang C, Pellicane J, Maganini R, Khan S, MacDermed DM, Small W, Mittal K, Borgen P, Cox C, Shivers SC, Bremer T. ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT^® PREDICT Study. Ann Surg Oncol. 2024 Sep;31(9):5959-5960. doi: 10.1245/s10434-024-15739-2. PMID: 39008205.

Document Type

Abstract

PubMed ID

39008205